- |||||||||| Avastin (bevacizumab) / Roche, Torisel (temsirolimus) / Pfizer
Trial completion, Trial primary completion date: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer (clinicaltrials.gov) - Jul 11, 2017
P2, N=252, Completed,
Active, not recruiting --> Completed | Trial primary completion date: Sep 2017 --> Mar 2017
- |||||||||| Avastin (bevacizumab) / Roche, Torisel (temsirolimus) / Pfizer
Trial primary completion date: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer (clinicaltrials.gov) - Mar 10, 2017
P2, N=299, Active, not recruiting,
Active, not recruiting --> Completed | Trial primary completion date: Sep 2017 --> Mar 2017 Trial primary completion date: Jun 2016 --> Sep 2017
- |||||||||| Avastin (bevacizumab) / Roche, Torisel (temsirolimus) / Pfizer
Trial primary completion date: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer (clinicaltrials.gov) - Feb 23, 2016
P2, N=299, Active, not recruiting,
Trial primary completion date: Jun 2016 --> Sep 2017 Trial primary completion date: Feb 2016 --> Jun 2016
- |||||||||| Avastin (bevacizumab) / Roche, Torisel (temsirolimus) / Pfizer
Trial primary completion date: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer (clinicaltrials.gov) - Jul 17, 2015
P2, N=299, Active, not recruiting,
Trial primary completion date: Feb 2016 --> Jun 2016 Trial primary completion date: Aug 2015 --> Dec 2015
- |||||||||| Avastin (bevacizumab) / Roche, Torisel (temsirolimus) / Pfizer
Trial primary completion date: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer (clinicaltrials.gov) - Feb 10, 2015
P2, N=299, Active, not recruiting,
N=158 --> 0 | Not yet recruiting --> Withdrawn Trial primary completion date: Mar 2015 --> Aug 2015
- |||||||||| Avastin (bevacizumab) / Roche, Torisel (temsirolimus) / Pfizer
Enrollment closed: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer (clinicaltrials.gov) - Jan 2, 2015
P2, N=299, Active, not recruiting,
Trial primary completion date: Mar 2015 --> Aug 2015 Recruiting --> Active, not recruiting
- |||||||||| Avastin (bevacizumab) / Roche, Torisel (temsirolimus) / Pfizer
Trial suspension: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer (clinicaltrials.gov) - Jul 16, 2014
P2, N=299, Suspended,
Recruiting --> Active, not recruiting Recruiting --> Suspended
|
